Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL
ClinicalTrials.gov study NCT00319930. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
ClinicalTrials.gov study NCT01295593. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06364423. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
ClinicalTrials.gov study NCT07024706. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01463852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypertension and Arrhythmias in CLL Patients Treated with BTK Inhibitors
ClinicalTrials.gov study NCT06211413. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01557777. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
ClinicalTrials.gov study NCT05959694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00151736. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01397916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice
ClinicalTrials.gov study NCT03310190. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ClinicalTrials.gov study NCT04771572. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation
ClinicalTrials.gov study NCT01809847. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
ClinicalTrials.gov study NCT04178317. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy
ClinicalTrials.gov study NCT00800943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
ClinicalTrials.gov study NCT04159779. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00758693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT07030400. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
ClinicalTrials.gov study NCT06548152. IPD Sharing: YES. Countries: 1. Publications: 0.
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04771507. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.